Literature DB >> 3248734

Cloning of a mammalian DNA methyltransferase.

T H Bestor1.   

Abstract

Cloning and sequencing of cDNA clones has shown that mammalian DNA (cytosine-5)-methyltransferase comprises a 1000-amino acid (aa) N-terminal region of unknown function and a 570-aa C-terminal region that is clearly related to bacterial type-II cytosine restriction methyltransferases. These findings indicate that the mammalian enzyme contains at least two structural domains and suggest a common evolutionary origin for mammalian and prokaryotic DNA (cytosine-5)-methyltransferases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3248734     DOI: 10.1016/0378-1119(88)90238-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  32 in total

Review 1.  AdoMet-dependent methylation, DNA methyltransferases and base flipping.

Authors:  X Cheng; R J Roberts
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

Review 2.  Molecular epigenetics and genetics in neuro-oncology.

Authors:  Raman P Nagarajan; Joseph F Costello
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

3.  Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1.

Authors:  K S Voo; D L Carlone; B M Jacobsen; A Flodin; D G Skalnik
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 4.  The dynamic nature of DNA methylation: a role in response to social and seasonal variation.

Authors:  Sebastian Alvarado; Russell D Fernald; Kenneth B Storey; Moshe Szyf
Journal:  Integr Comp Biol       Date:  2014-05-10       Impact factor: 3.326

5.  Genome-wide DNA methylation profiling in triple-negative breast cancer reveals epigenetic signatures with important clinical value.

Authors:  Clare Stirzaker; Elena Zotenko; Susan J Clark
Journal:  Mol Cell Oncol       Date:  2015-05-26

6.  Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.

Authors:  C Stirzaker; J Z Song; W Ng; Q Du; N J Armstrong; W J Locke; A L Statham; H French; R Pidsley; F Valdes-Mora; E Zotenko; S J Clark
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

Review 7.  The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer.

Authors:  J L Salisbury
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 8.  Epigenetics of neurological cancers.

Authors:  Shaun D Fouse; Joseph F Costello
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

9.  Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation.

Authors:  Helai P Mohammad; Yi Cai; Kelly M McGarvey; Hariharan Easwaran; Leander Van Neste; Joyce E Ohm; Heather M O'Hagan; Stephen B Baylin
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

Review 10.  Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Giuseppe Leone; Francesco D'Alò; Giuseppe Zardo; Maria Teresa Voso; Clara Nervi
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.